Scleromyxedema: Treatment with interferon alfa

Journal of the American Academy of Dermatology

Volumn 40, Issue 2 II SUPPL., 1999, Pages 303-307

  Tschen, J A ^a   Chang, J R ^a  

^a Departments of Dermatopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; DRUG ERUPTION; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; LICHENOID ERUPTION; MUCINOSIS; MYXEDEMA; PRIORITY JOURNAL; PRURITUS; SCLEROMYXEDEMA; SCLEROSIS; SKIN DEFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033013986     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(99)70471-8     Document Type: Article

References (21)

1. AO Harris AR Altman JA Tschen JE. Wolf Scleromyxedema Int J Dermatol 28 1989 661 667
2. EJ Fudman J Golbus RW. Ike Scleromyxedema with systemic involvement mimics rheumatic diseases Arthritis Rheum 29 1986 913 917
3. TR Alligood JW Burnett LR. Bannister Scleromyxedema associated with esophageal aperistalsis and dermal eosinophilia Cutis 28 1981 60 64
4. AP Truhan HH. Roenigk Lichen myxedematosus: an unusual case with rapid progression and possible internal involvement Int J Dermatol 26 1987 91 95
5. LV. Jepsen Two cases of scleromyxedema Acta Derm Venereol (Stockh) 60 1980 77 79
6. SM Howsden JH Herndon RG. Freeman Lichen myxedema-losus: a dermal infiltrative disorder responsive to cyclophosphamide therapy Arch Dermatol 111 1975 1325 1330
7. RT Jessen M Straight LE. Becker Lichen myxedematosus: treatment with cyclophosphamide Int J Dermatol 17 1978 833 839
8. JM Wieder KL Barton JM Baron K. Soltani Lichen myxedematosus treated with chlorambucil J Dermatol Surg Oncol 19 1993 475 476
9. TG Hill JN Crawford CC. Rogers Successful management of lichen myxedematosus Arch Dermatol 112 1976 67 69
10. AW MacFarlane A Davenport JL Verbov HJ Goldsmith Scleromyxedema—successful treatment with plasma exchange and immunosuppression Br J Dermatol 117 1987 653 657
11. LS Davis S Sanal OP. Sangueza Treatment of scleromyxedema with 2-chloro-deoxyadenosine J Am Acad Dermatol 35 1996 288 290
12. A Yen RL Sanchez SS. Raimer Papular mucinosis associated with AIDS: Response to isotretinoin J Am Acad Dermatol 37 1997 127 128
13. BM Hisler B Savoy K. Hashimoto Improvement of scleromyxedema associated with isotretinoin therapy J Am Acad Dermatol 24 1991 854 857
14. M Berkson GS Lazarus M Uberti-Benz AH. Rook Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedema J Am Acad Dermatol 25 1991 724
15. RA Harper J. Rispler Lichen myxedematosus serum stimulates human skin fibroblast proliferation Science 199 1978 545 547
16. M Yaron I Yaron I Yust S. Brenner Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts J Rheumatol 12 1985 171 175
17. MR Duncan B. Berman Persistence of a reduced collagen-producing phenotype in cultured scleroderma fibroblasts after short term exposure to interferons J Clin Invest 79 1987 1318 1324
18. B Berman MR. Duncan Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro J Am Acad Dermatol 21 4 pt 1 1989 694 702
19. B Berman M. Sequeira Dermatologic uses of interferons Dermatol Clin 13 1995 699 711
20. R Ucar M Sanwo K Ucar G. Beall Interferons: their role in clinical practice Ann Allergy Asthma Immunol 75 1995 377 383
21. GL Peck JJ. DiGiovanna Retinoids 4th ed TB Fitzpatrick AZ Eisen K Wolff Dermatology in general medicine 1993 McGraw-Hill New York 2883 2908